BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31918808)

  • 1. Physostigmine for Antimuscarinic Toxicity.
    Saadi R; Bohnenberger K
    J Emerg Nurs; 2020 Jan; 46(1):126-128. PubMed ID: 31918808
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial comparing physostigmine vs lorazepam for treatment of antimuscarinic (anticholinergic) toxidrome.
    Wang GS; Baker K; Ng P; Janis GC; Leonard J; Mistry RD; Heard K
    Clin Toxicol (Phila); 2021 Aug; 59(8):698-704. PubMed ID: 33295809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged Antimuscarinic Delirium in a Child Due to Benztropine Exposure Treated With Multiple Doses of Physostigmine.
    Thornton SL; Farnaes L; Minns A
    Pediatr Emerg Care; 2016 Apr; 32(4):243-5. PubMed ID: 26383155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine.
    Whitledge JD; Watson CJ; Simpson M; Bakkar A; Boussi L; Scott M; Boyle KL
    J Med Toxicol; 2023 Apr; 19(2):219-223. PubMed ID: 36575250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing and frequency of physostigmine redosing for antimuscarinic toxicity.
    Rosenbaum C; Bird SB
    J Med Toxicol; 2010 Dec; 6(4):386-92. PubMed ID: 20405266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physostigmine versus diazepines for anticholinergic poisoning.
    Oakley P
    Ann Emerg Med; 2001 Feb; 37(2):239-41. PubMed ID: 11174251
    [No Abstract]   [Full Text] [Related]  

  • 7. A picturesque reversal of antimuscarinic delirium.
    Richardson WH; Williams SR; Carstairs SD
    J Emerg Med; 2004 May; 26(4):463. PubMed ID: 15093860
    [No Abstract]   [Full Text] [Related]  

  • 8. Physostigmine is superior to non-antidote therapy in the management of antimuscarinic delirium: a prospective study from a regional poison center.
    Boley SP; Olives TD; Bangh SA; Fahrner S; Cole JB
    Clin Toxicol (Phila); 2019 Jan; 57(1):50-55. PubMed ID: 29956570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivastigmine Use in the Treatment of Antimuscarinic Delirium.
    Greene SC
    J Med Toxicol; 2023 Jul; 19(3):284-287. PubMed ID: 37204613
    [No Abstract]   [Full Text] [Related]  

  • 10. Rivastigmine for the management of anticholinergic delirium.
    Chiew AL; Holford AG; Chan BSH; Isoardi KZ
    Clin Toxicol (Phila); 2024 Feb; 62(2):82-87. PubMed ID: 38465631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and effectiveness of physostigmine: a 10-year retrospective review.
    Arens AM; Shah K; Al-Abri S; Olson KR; Kearney T
    Clin Toxicol (Phila); 2018 Feb; 56(2):101-107. PubMed ID: 28703024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological management of anticholinergic delirium - theory, evidence and practice.
    Dawson AH; Buckley NA
    Br J Clin Pharmacol; 2016 Mar; 81(3):516-24. PubMed ID: 26589572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a physostigmine continuous infusion for the treatment of severe and recurrent antimuscarinic toxicity in a mixed drug overdose.
    Phillips MA; Acquisto NM; Gorodetsky RM; Wiegand TJ
    J Med Toxicol; 2014 Jun; 10(2):205-9. PubMed ID: 24798647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Datura and Brugmansia plants related antimuscarinic toxicity: an analysis of poisoning cases reported to the Taiwan poison control center.
    Doan UV; Wu ML; Phua DH; Mendez Rojas B; Yang CC
    Clin Toxicol (Phila); 2019 Apr; 57(4):246-253. PubMed ID: 30522351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physostigmine for Facilitation of Care in Clozapine-Associated Anticholinergic Delirium.
    Spring JD; Goldstein BN; Buster M; Mahmoud AA; Hamm B
    J Clin Psychopharmacol; 2022 May-Jun 01; 42(3):329-331. PubMed ID: 35260542
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful management of olanzapine-induced anticholinergic agitation and delirium with a continuous intravenous infusion of physostigmine in a pediatric patient.
    Hail SL; Obafemi A; Kleinschmidt KC
    Clin Toxicol (Phila); 2013 Mar; 51(3):162-6. PubMed ID: 23473460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of nonanticholinergic delirium with a cholinesterase inhibitor.
    Fischer P
    J Clin Psychopharmacol; 2001 Feb; 21(1):118. PubMed ID: 11199939
    [No Abstract]   [Full Text] [Related]  

  • 18. Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication.
    Van Kernebeek MW; Ghesquiere M; Vanderbruggen N; Verhoeven E; Hubloue I; Crunelle CL
    Clin Toxicol (Phila); 2021 May; 59(5):447-448. PubMed ID: 32960128
    [No Abstract]   [Full Text] [Related]  

  • 19. Physostigmine as treatment for severe CNS anticholinergic toxicity.
    Teoh R; Page AV; Hardern R
    Emerg Med J; 2001 Sep; 18(5):412. PubMed ID: 11559630
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning.
    Burns MJ; Linden CH; Graudins A; Brown RM; Fletcher KE
    Ann Emerg Med; 2000 Apr; 35(4):374-81. PubMed ID: 10736125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.